Application 213220
- Type
- ANDA
- Sponsor
- MSN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOFETILIDE | DOFETILIDE | CAPSULE;ORAL | 0.125MG | No | No |
| 002 | DOFETILIDE | DOFETILIDE | CAPSULE;ORAL | 0.25MG | No | No |
| 003 | DOFETILIDE | DOFETILIDE | CAPSULE;ORAL | 0.5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213220-001 | DOFETILIDE | DOFETILIDE | 0.125MG | CAPSULE / ORAL | AB | 2020-01-29 | |
| A213220-002 | DOFETILIDE | DOFETILIDE | 0.25MG | CAPSULE / ORAL | AB | 2020-01-29 | |
| A213220-003 | DOFETILIDE | DOFETILIDE | 0.5MG | CAPSULE / ORAL | AB | 2020-01-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213220-001 | AB |
| A213220-002 | AB |
| A213220-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A213220-001 | DOFETILIDE | 0.125MG | CAPSULE / ORAL | AB | 2020-01-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A213220-002 | DOFETILIDE | 0.25MG | CAPSULE / ORAL | AB | 2020-01-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A213220-003 | DOFETILIDE | 0.5MG | CAPSULE / ORAL | AB | 2020-01-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A213220-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A213220-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A213220-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dofetilide | DOFETILIDE | REMEDYREPACK INC. | a5d943c6-1960-4318-9e6f-6bf69ac49953 | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 213220 ANDA213220 |
| Dofetilide | DOFETILIDE | Novadoz Pharmaceuticals LLC | b8323987-90fe-4e6c-a71c-76e3c501713c | 2022-07-29 | Boxed warning, Warnings, Adverse reactions | 213220 ANDA213220 72205-039 72205-040 72205-041 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69539-130 | Dofetilide | Dofetilide | MSN LABORATORIES PRIVATE LIMITED | ANDA | Current |
| 69539-131 | Dofetilide | Dofetilide | MSN LABORATORIES PRIVATE LIMITED | ANDA | Current |
| 69539-132 | Dofetilide | Dofetilide | MSN LABORATORIES PRIVATE LIMITED | ANDA | Current |
| 72205-039 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-039 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-040 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-040 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-041 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-041 | Dofetilide | Dofetilide | Novadoz Pharmaceuticals LLC | ANDA | Current |